Mastery EAQ Ch. 13

A  Onset after the age 7 years. Learning disability with signs of depression. Acting out during school or in the home

B  Onset after the age 7 years. Short attention span for the child’s age. Acting out during school or in the home

C  Symptoms lasting at least 6 months. Learning disability with signs of depression. Acting out during school or in the home

D  Lack of ability to control impulses. Symptoms lasting at least 6 months. Short attention span for the child’s age

A  Pain status

B  Activity level

C  Dietary intake

D  Vital signs

A  Responds to command to use incentive spirometer

B  Pulse of 98 beats per minute

C  Respiratory rate of 16 breaths per minute

D  Carbon dioxide arterial blood gas levels increase

A  Hangover effect

B  Serotonin syndrome

C  Caffeine withdrawal

D  Rebound headache

A  Onset of confusion, History of chronic headache, Blood pressure of 168/94 mmHg, Two previous sumatriptan injections at 0800 and 1200

B  Onset of confusion, Slurred speech, Blood pressure of 168/94 mmHg, Two previous sumatriptan injections at 0800 and 1200

C  Onset of confusion, Slurred speech, History of chronic headache, Two previous sumatriptan injections at 0800 and 1200

D  Onset of confusion, Slurred speech, Blood pressure of 168/94 mmHg, History of chronic headache

A  Schedule I

B  Schedule IV

C  Schedule II

D  Schedule III

A  Caffeine

B  Morphine

C  Diazepam

D  Phenobarbitone

A  Suicidal tendencies

B  Addiction

C  Mood swings

D  Sleeplessness

A  Orlistat

B  Sumatriptan

C  Caffeine

D  Atomoxetine

A  Methylphenidate

B  Amphetamine aspartate

C  Dextroamphetamine sulfate

D  Atomoxetine

A  Postanesthetic respiratory depression and Migraines

B  End-stage heart failure and Peptic ulcer disease

C  Bronchopulmonary dysplasia and Migraines

D  Postanesthetic respiratory depression and Bronchopulmonary dysplasia

A  Relaxes the bronchial smooth muscle. Increases sensitivity to carbon dioxide. Supports a regular pattern of breathing. Blocks the action of cerebral adenosine.

B  Promotes constriction of the bronchi. Blocks the action of cerebral adenosine. Increases the production of surfactant.

C  Promotes constriction of the bronchi. Increases the production of surfactant. Increases sensitivity to carbon dioxide.

D  Relaxes the bronchial smooth muscle. Promotes constriction of the bronchi. Increases the production of surfactant.

A  Modafinil for shift work sleep disorder

B  Dextroamphetamine for narcolepsy

C  Atomoxetine for attention-deficit/hyperactivity disorder

D  Orlistat for weight loss management

A  Preceding morning school activities daily

B  Before breakfast on weekdays

C  Early afternoon when restlessness occurs

D  At least 4 hours before bedtime

A  Supplement the diet with fat-soluble vitamins.

B  Take the medication with an antacid.

C  Increase fluid and fiber in the diet.

D  Limit dietary intake of fat to less than 30% of total calories.

A  Phentermine

B  Modafinil

C  Naratriptan

D  Orlistat

A  Take the medication with a lot of fluids.

B  Take ice chips for relief of headache.

C  Do not take phentermine.

D  Take acetaminophen.

A  Amphetamine aspartate

B  Armodafinil

C  Orlistat

D  Methylphenidate

A  Substance abuse treatment

B  Respiratory therapy

C  Dietary referral

D  Pain management

A  Reduce the dose of the medication slightly.

B  Switch the child to caffeine, which is a more natural stimulant.

C  Talk to the health care provider about instituting “drug holidays.”

D  Use deep breathing exercises instead of medication to keep the child calm.

A  “This is the normal behavior of a 7-year-old child.”

B  “Your child has attention-deficit/hyperactivity disorder.”

C  “You should continue to observe the child’s behavior for 4 months.”

D  “You should consult a child psychiatrist immediately.”

A  “Ask the primary health care provider to prescribe an oral hypoglycemic medication.”

B  “Ask the primary health care provider to prescribe an anorexiant because it will reduce obesity.”

C  “You should follow a nutrition and exercise regimen for weight management.”

D  “You should drink coffee and alcohol once a week to reduce obesity.”

A  The patient has been taking this medication for a long time.

B  The patient has been taking reduced doses of medication.

C  The patient has not followed the dosing schedule as prescribed.

D  The patient has taken the medication with excess amounts of fluids.

A  Orlistat

B  Phentermine

C  Benzphetamine

D  Methamphetamine

A  “This drug has many side effects.”

B  “This drug causes hallucinations.”

C  “This drug causes amenorrhea.”

D  “This drug has a high risk of abuse.”

A  Methylphenidate

B  Benzphetamine

C  Atomoxetine

D  Modafinil

A  Caffeine

B  Almotriptan

C  Dextroamphetamine

D  Phentermine

A  Atomoxetine and orlistat

B  Modafinil and doxapram

C  Modafinil and sumatriptan

D  Doxapram and sumatriptan

A  Avoid dissolving the sustained-release medications in water. Administer the medication after meals. Administer the medication 2 hours before going to bed.

B  Avoid administering medications on weekends. Avoid dissolving the sustained-release medications in water. Administer the medication before sending the child to school.

C  Administer the medication after meals. Administer the medication before sending the child to school. Administer the medication 2 hours before going to bed.

D  Administer the medication after meals. Administer the medication 2 hours before going to bed. Avoid administering medications on weekends.

A  “If I notice side effects of these medications, I should stop giving the drug immediately and notify the provider.”

B  “It is permissible to crush extended-release medications for patients who have difficulty swallowing pills.”

C  “I will give these drugs 30 to 45 minutes before meals to improve absorption.”

D  “I may dispense these medications to nursing staff if needed.”

A  Chest congestion

B  Diarrhea

C  Fecal incontinence

D  Enhanced urinary output

A  Naratriptan and Zolmitriptan

B  Diazepam and Ergotamine

C  Ergotamine and Sibutramine

D  Diazepam and Atomoxetine

A  The patient has diabetes.

B  The patient is taking antiviral medications.

C  The patient has glaucoma.

D  The patient is taking monoamine oxidase inhibitors (MAOIs).

A  Insomnia

B  Bradycardia

C  Hypotension

D  Decreased mental alertness

A  Bradycardia

B  Syncope

C  Drowsiness

D  Increased blood pressure

A  Dizziness, Numbness, Nasal irritation

B  Tingling, Flushing, Numbness

C  Tingling, Dizziness, Flushing

D  Nasal irritation, Tingling, Flushing

A  Nutrition deficiency

B  Gastric ulcers

C  Hyperglycemia

D  Insomnia

A  Dexmethylphenidate does not improve attention.

B  Dexmethylphenidate induces sedation in the child.

C  Dexmethylphenidate is contraindicated in pediatric patients.

D  Dexmethylphenidate has more addictive properties.

A  Daytime sleepiness, Photophobia, Skeletal muscle weakness

B  Phonophobia, Daytime sleepiness, Skeletal muscle weakness

C  Photophobia, Phonophobia, Pulsating headache

D  Pulsating headache, Daytime sleepiness, Skeletal muscle weakness

A  Increased appetite, Insomnia, Decreased blood pressure

B  Insomnia, Headache, Weight loss

C  Headache, Increased appetite, Decreased blood pressure

D  Weight loss, Increased appetite, Decreased blood pressure

A  Headache, Severe hypertension

B  Seizures, Insomnia, Dysrhythmias

C  Headache, Severe hypertension

D  Headache, Severe hypertension

A  Glaucoma, Drug allergies, Bulimia nervosa

B  Hypotension, Bulimia nervosa, Hypothyroidism

C  Drug allergies, Hypotension, Hypothyroidism

D  Hypotension, Hypothyroidism, Glaucoma

A  “They increase the effect of norepinephrine.”

B  “It may decrease my heart rate.”

C  “I should not take these medications at least 1 day per week.”

D  “They block the reuptake of dopamine.”

A  120 mg at each meal

B  50 mg as a single dose

C  20 mg after lunch

D  5 mg before breakfast and lunch

A  Sumatriptan

B  Orlistat

C  Dextroamphetamine

D  Modafinil

A  Phosphodiesterase inhibitors

B  Ergot alkaloids

C  Lipase inhibitors

D  Serotonin receptor agonists

A  Medulla and brainstem

B  Hypothalamic and limbic regions

C  Cerebral cortex

D  Cerebrovascular system

A  Theophylline

B  Aminophylline

C  Doxapram

D  Caffeine

A  200 mg

B  100 mg

C  40 mg

D  32 mg

A  To reduce blood pressure. To reduce blood glucose level.

B  To reduce blood glucose level. To reduce uric acid levels.

C  To increase the rate of respiration. To increase the depth of respiration

D  To reduce uric acid levels. To reduce blood pressure

A  Sumatriptan

B  Modafinil

C  Atomoxetine

D  Phentermine

A  Skeletal muscle weakness

B  Pulsating headache

C  Hyperactivity

D  High body mass index (BMI)

A  Narcolepsy

B  Attention-deficit/hyperactivity disorder

C  Migraine

D  Postanesthetic respiratory depression

A  Orlistat

B  Atomoxetine

C  Amphetamine

D  Phentermine